Circulating levels of insulin‐like growth factor I, its binding proteins ‐1,‐2, ‐3, C‐peptide and risk of postmenopausal breast cancer

Higher levels of circulating Insulin‐like Growth Factor (IGF)‐I may be associated with higher risks for premenopausal breast cancer. We investigate the associations between circulating levels of IGF‐I, its binding proteins (IGFBPs) ‐1, ‐2, ‐3, C‐peptide and postmenopausal breast cancer. This is a pr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cancer 2003-08, Vol.106 (1), p.90-95
Hauptverfasser:	Keinan‐Boker, Lital, Bueno de Mesquita, H. Bas, Kaaks, Rudolf, van Gils, Carla H., van Noord, Paul A.H., Rinaldi, Sabina, Riboli, Elio, Seidell, Jaap C., Grobbee, Diederick E., Peeters, Petra H.M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Apoptosis Biological and medical sciences breast cancer Breast Neoplasms - blood C-Peptide - blood Cohort Studies C‐peptide Female Gynecology. Andrology. Obstetrics Humans IGF binding proteins (IGFBP) ‐1,‐2, ‐3 Insulin-Like Growth Factor Binding Protein 1 - blood Insulin-Like Growth Factor Binding Protein 2 - blood Insulin-Like Growth Factor Binding Protein 3 - blood Insulin-Like Growth Factor I - biosynthesis insulin‐like growth factor‐I (IGF‐I) Mammary gland diseases Medical sciences Middle Aged Odds Ratio postmenopausal Postmenopause prospective Prospective Studies Registries Risk Factors Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!